NH - ナチュラル・ヘルス・トレンズ (NantHealth Inc.)

NHのニュース

   NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript  2021/08/06 02:50:43 Seeking Alpha
   NantHealth EPS beats by $0.02, misses on revenue  2021/08/05 20:32:18 Seeking Alpha
   NantHealth Reports 2021 Second Quarter Financial Results  2021/08/05 20:05:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2021. Our 2021 second-quarter financial results were in-line with our expectations and remained steady compared with the previous quarter, said Ron Louks, Chief Operating Officer, NantHealth. "We are focused on investing in our business through the
   NantHealth picks internal candidate for medical chief  2021/08/03 13:40:26 Seeking Alpha
   Future Trend & Forecast of Medical Device Interoperability Market by Regions, Type, Application, Forecast (2021-2030) with Leading Players- NantHealth Inc., Bernoulli Enterprise Inc., iHealth Lab Inc.  2021/08/03 11:29:19 OpenPR
The research report titled as, Medical Device Interoperability Market has recently added by Absolute Markets Insights to its massive database which offers a clear understanding of various business aspects of the Medical Device Interoperability market. This research report has been
   NantHealth and Sesame Announce Collaboration to Help Providers Increase Productivity and Better Serve Patients  2021/01/25 13:00:00 Business Wire
NEW YORK & EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a collaboration with Sesame, a direct-to-patient healthcare platform offering affordable prices for in-person and virtual care. The program gives providers the tools needed to offer patients direct access to affordable, high-quality care while increasing practice revenue up to 25% per patient visit
   5 Top Stock Gainers for Friday: Disney, FAT Brands  2020/12/11 17:46:16 The Street
Walt Disney, vTv Therapeutics, Nanthealth, Solid Biosciences and FAT Brands are five of the top stock gainers for Friday.
   Disney, FAT Brands: 5 Top Stock Gainers for Friday  2020/12/11 17:46:00 Yahoo Finance
Walt Disney, vTv Therapeutics, Nanthealth, Solid Biosciences and FAT Brands are five of the top stock gainers for Friday.
   NantHealth and ImmunityBio Announce RNA Profiling for Clinical Decision Support Publication In Nature’s Scientific Reports  2020/11/17 13:00:00 Business Wire
CULVER CITY, Calif. & EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the publication of a study that revealed RNA sequencing is not only viable but may also provide significant clinical value in analyzing a cancer patient’s specific disease biology to enable an optimized treatment decision with a higher likelihood of success. The study was published in Na
   Combination of Deep-Learning Models Provides Significant Risk-Assessment of Survival in Pancreatic Cancer Patients, Holding Promise as a Prognostic Technology  2020/10/13 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, presented virtually with NantOmics and ImmunityBio on September 29-30 2020, a session entitled “Deep-learning image-based tumor, stroma and lymphocytes spatial relationships and clinical features that affect survival in pancreatic cancer patients,” at the American Association for Cancer Research (AACR) virtual special conference on pancreatic cancer. This Nant
   NantHealth Enhances Interoperability of the NaviNet Open Platform With Expanded API Capabilities  2020/09/23 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced a series of secure Application Programming Interfaces (APIs) that will offer provider and revenue cycle organizations connectivity to payers via the NaviNet Open Platform. This update enables faster information retrieval and easier payer access through a secure real-time, HIPAA-compliant gateway to payers. The workflows include Eligibility &
   NantHealth Rolls Out NaviNet AllPayer Platform Nationally  2020/09/22 13:15:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the national rollout of NaviNet AllPayer, a subscription-based platform allowing providers increased visibility into standard eligibility and benefit information for over 1,000 commercial and government health plans using a single login. Providers can also check claim status for over 550 health plans. AllPayer eliminates the need to sign-in to multip
   NantHealth Acquires OpenNMS | FinSMEs  2020/07/28 09:16:19 FinSMEs
NantHealth, Inc. (NASDAQ: NH), a Culver City, Calif.-based next-generation, evidence-based, personalized healthcare company, acquired The OpenNMS Group, a Morrisville, NC-based open-source network management company
   NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform  2020/07/27 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the acquisition of The OpenNMS Group, Inc. (www.opennms.com), the world’s premier open-source network management company, which will operate as a subsidiary of NantHealth. The transaction closed on July 22, 2020. “OpenNMS has set the standard for open-source network monitoring since 2000 with its enterprise-grade network management platform,” s
   NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance  2020/06/25 12:00:00 Business Wire
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer-reviewed journal dedicated to biomedical research from preclinical to clinical studies. This research looked into the discordance between genomic sequencing and transcriptome analysis, and how this may reflect a mechanism of resistance to therapy in tumors that has previously been under-recogniz

calendar